Background: Helicobacter pylori infection is associated with lowgrade gastric MALT lymphoma, and available data support that the eradication of the H. pylori can cause histological regression of the lymphoma.
Introduction
Gastric lymphoma is the most frequent extranodal lymphoma and most cases are low-grade lymphomas derived from the mucosa-associated lymphoid tissue (MALT) [1] . The cornerstone for the understanding of MALT-derived gastric lymphomas has been the evidence of their association with H. pylori: the association between colonization of gastric mucosa by H. pylori and development of MALT tissue and gastric lymphoma [2] , the increased incidence of gastric lymphoma in areas where the prevalence of H. pylori is also higher [3] , and the epidemiological association of gastric lymphoma with previous H. pylori infection [4] . Further steps have been the demonstration that strains of H. pylori can induce T-cell-mediated proliferative responses of low-grade gastric MALT lymphomas [5] and the regression of the low-grade MALT lymphomas after eradication of H. pylori [6] . We refer to the outcome of nine patients with low-grade gastric MALT lymphoma who, after treatment for eradication of H. pylori, have been followed up with sequential histological study and PCR amplification of the IgH gene.
Patients and methods
Nine patients with low-grade gastric MALT lymphoma newly diagnosed at the Hospital Ramon y Cajal (in Madrid, Spain) from December 1993 to July 1995 were included in a prospective study. Diagnosis was established by means of endoscopic biopsies obtained from the fundus, body of the stomach, antrum, duodenum, and from any macroscopic tumor or suspicious area. Endoscopic patterns were considered as infiltration, ulceration, or tumor pattern, as described elsewhere [7] . A 'chronic gastritis pattern' described the presence of irregular patchy erythematous lesions. Other minor endoscopical changes were accepted as normal. Biopsy samples were routinely processed for histological study and stained with H & E and Giemsa. Low-grade MALT lymphoma was diagnosed when unequivocal histological features, infiltration by centrocyte-like cells, follicular colonization, and lymphoepithelial lesions were identified [1] . Fresh samples were obtained for culture of H. pylori (in a nonselective and in a microaerophilic selective media) and for molecular studies performed by means of PCR amplification of the IgH gene. Staging procedures included physical examination, standard blood and biochemical parameters, chest and abdominal CT scan, and bone marrow biopsy. Only patients with localized gastric disease, stage I E of the Ann Arbor system, were eligible for the treatment protocol. All patients accepted their inclusion in the study. All patients received eradication therapy that consisted of amoxicillin 750 mg plus metronidazole 500 mg three times daily and omeprazole 40 mg twice daily for 14 days. Patients were followed up with sequential clinical and endoscopical examinations. Mapped biopsies were obtained for the endoscopic reevaluation and processed as in the initial study. In order to demonstrate the eradication of H. pylori, breath test urea-' 3 C was also performed in the successive reevaluations. In the follow-up studies, complete histological regression was accepted when no definitive lymphoma was demonstrated in the biopsies (grade 0 to 3 according to the scoring of Wotherspoon and others [6] and partial regression when grade 4 was demonstrated.
Polymerase chain reaction (PCR) analysis
Amplification of the IgH gene was performed on all samples using a seminested procedure with consensus primers for the V H region (Fr3A or Fr2A) in conjunction with nested primers directed to the J H region (LJH and VLJH), as described elsewhere [8] .
Results
Mean age of the patients was 60 ± 9 (range 42-76). At diagnosis, endoscopy showed an infiltration pattern in six patients (66.6%) and an ulceration pattern in three. H. pylori was demonstrated in the biopsy samples in all cases by culture and/or histology. H. pylori was successfully eradicated in all patients and reinfection was not demonstrated throughout the follow-up period. The follow-up endoscopic, histological, and molecular findings after eradication therapy for H. pylori are shown in Table  1 . The endoscopic pattern suggestive of lymphoma regressed in all cases. In two patients, the infiltration pattern persisted after initial treatment, but also regressed in the subsequent endoscopies. In case 1, biopsies taken 1 and 4 months after eradication therapy demonstrated MALT lymphoma and the patient was then treated with surgery achieving a complete cure of the lymphoma. Histological regression of the lymphoma was observed after H. pylori eradication therapy in the remaining eight patients (88.8%). In patients 2, 4, and 8, the first endoscopic control demonstrated only partial histological regression, but the regression was complete 5, 7, and 5 months, respectively, after the initial eradication therapy without any further treatment. In the PCR analysis no clonal band was detected along with the histological regression of the lymphoma in four of the eight patients (patients 5, 6, 7, and 9). In patients 2, 3, 4, and 8, a clonal IgH gene rearrangement was demonstrated after eradication treatment despite histological regression of the lymphoma, but it was no longer present 11, 20, 7, and 12 months, respectively, after treatment (mean 12 ± 4 months). In patients 2 and 3, a clonal band was transiently identified 3 and 4 months, respectively, after a previously negative analysis, but it has subsequently disappeared in both patients. Altogether, no clonal band was detected by the PCR analysis in any of the eight patients after a median of 7 ± 6 months (range 1-20). Patient 5 was lost for followup, but all the remaining seven patients who achieved a regression of the lymphoma have been followed up without additional treatment and are in histological, clinical, and molecular remission a mean of 14 ± 5 months (range 7-22) after treatment.
Discussion
Available data support that eradication therapy for H. pylori can make most localized low-grade gastric MALT lymphoma regress [9] [10] [11] , although in some cases complete histological regression can take some time to occur [11] , and in others, the finding of a clonal band in the PCR analysis suggests the persistence of a clonal lymphoid population [9, 11] . In the series of Wotherspoon [9] , Roggero [10] , and Bayerdorffer [11] , histological regression was achieved in 87%, 60%, and 70% of the patients, respectively. Moreover, 14 of the 15 patients (93%) in the Roggero series [10] and all the patients in the Bayerdorffer series [11] who achieved a complete regression of the lymphoma did maintain the remission after a median follow-up of one year. It is also remarkable that despite a complete histological regression of the lymphoma, PCR studies demonstrated a clonal band in 3 of the 7 studied patients (42%) in the Wotherspoon series [9] and in 3 of the 16 studied patients (18%) in the Bayerdorffer series [11] .
In the Madrid area, the prevalence of H. pylori infection in healthy subjects is 60.3% [12] . The exact incidence of gastric MALT lymphoma is not known, but the results of the present series confirm that in our environment most patients with low-grade gastric MALT lymphoma can be histologically cured after the eradication of H. pylori. However, a more sensitive technique is necessary to evaluate whether the lymphoma has actually disappeared or a persistent clonal population remains. The aim in our study has been to evaluate the histological and molecular evolution of the lymphoma after treatment, following up the patients with sequential clinical and histological studies and with PCR amplification of the IgH gene. As PCR analysis is a most sensitive technique, the presence of a clonal band is a good marker to follow up the progress of the clonal lymphoid population in serial biopsy specimens. Using PCR procedure, we have detected that a clonal band persisted in half of the patients despite the apparent histological cure. The presence of this clonal band raised the ultimate question for the management of the patients: what to do with those patients with a clonal band in the absence of overt histologically demonstrated lymphoma. When we were initially faced with this problem, we decided to observe the evolution of the band and to follow up the patients closely with no other treatment [13] . In the present study, when the patients had a longer follow-up, it was demonstrated that although the clonal band persisted in some cases for as long as 20 months after eradication treatment, it finally disappeared in all cases. However, in two patients PCR failed to detected clonal bands that were nevertheless detected in later studies: this failure may be attributable to artifacts in the biopsy sampling, but sequential PCR analysis can contribute to minimize the risk of false negatives and to confirm the disappearance or persistence of the clonal population. In the present series, none of the patients achieving histological regression of the lymphoma after eradication therapy relapsed, and all the followed-up patients had maintained remission after a mean of 14 ± 5 months. The evolution of the clonal band in these patients indicates that cure may not be a clear-cut process, but a progressive one where the clonal population can take months to disappear. This is a most striking observation and support that the patients should not be treated unless the lymphoma becomes histologically evident.
The H. pylori eradication therapy for low-grade gastric MALT lymphoma has revolutionized the therapeutic approach to this disease. At present, it seems clear that patients in stage I E should be initially treated in this fashion. However, in some patients the histological regression may be delayed and in others the molecular response may take longer. When H. pylori eradication fails to achieve an objective histological regression of the lymphoma in sequential biopsies, presence of a highgrade lymphoma has to be suspected [11, 14] . The detection of a persistent clonal band in the sequential studies is not an indication for other treatments, which should be started only when active unresponsive low-grade lymphoma can be unequivocally demonstrated. In such cases, we feel that patients should be treated with surgery as, in our experience, this treatment has determined a good outcome for patients with localized disease [7] .
The ultimate fate of patients with low-grade gastric MALT lymphoma after H. pylori eradication is still unknown. However, the disappearance of the histologically detectable lymphoma and that of the clonal population suggests that the lymphoma might have achieved a real cure. To elucidate the long-term outcome of these patients, a prolonged clinical, endoscopic, histologic, and molecular follow-up is essential.
